Drug Discovery

Novozymes Biopharma is teaming up with Almac to provide a combined service for drug development applications in the field of drug targeting and pharmacokinetic improvements.

Studies in a mouse model of Alzheimer’s disease (AD) have shown how a drug that was originally developed to treat type 2 diabetes can reverse memory loss and boost neuroprotection in a mouse model of AD.

Ophthotech has expanded its eye disease treatment pipeline today by acquiring a small-molecule, age-related retinal disease therapy developer, as well as launching its third...

Prospective study finds no benefit of adding chemotherapy to hormone treatment for early breast cancer patients who have an intermediate Oncotype Dx gene expression assay score

Team says research results show existing safe-in-human broad-spectrum antivirals could be used on other viral infections.

International research team says focus should now be on deprescribing to limit the potential harm associated with anticholinergic drugs.

Partners aim to develop preclinical Empowered Cytokines that target IL4R

A new antiviral drug candidate attacks the Zika virus where it may be most vulnerable—the lipid membrane, which envelopes Zika’s RNA payload. The drug...

Immuno-oncology collaborations numbers keep climbing.

Active pharmaceutical ingredient from coralberry leaves might serve as a novel treatment for asthma